{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:35:30Z","timestamp":1790116530002,"version":"4.0.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":2366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III\u201d","doi-asserted-by":"publisher","award":["CPI13\/00065"],"award-info":[{"award-number":["CPI13\/00065"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III\u201d","doi-asserted-by":"publisher","award":["CPII13\/00023"],"award-info":[{"award-number":["CPII13\/00023"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondo Europeo de Desarrollo Regional FEDER","award":["AP2009-4537"],"award-info":[{"award-number":["AP2009-4537"]}]}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diabetes and cardiovascular disease are risk factors for erectile dysfunction (ED). Selective inhibitors of the type 5 phosphodiesterase are the first option for treating ED. However, it is unknown why there are patients with low response to this treatment. Polymorphisms in the PDE5A gene may influence the response to PDE5 inhibitors treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The aim of this study is to analyze the relationship between PDE5A polymorphisms, diabetes, and the efficacy of sildenafil treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A Spanish prospective cohort of 170 Caucasian male patients diagnosed with ED and ischemic heart disease treated with angioplasty was studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>ED was evaluated according to the 5-item version of the International Index for Erectile Function before and after treatment with sildenafil 50 mg. The gene sequence of the PDE5A gene was analyzed for the presence of rs12646525 and rs3806808 polymorphisms. Glucose and glycosylated hemoglobin levels were measured in blood serum samples. The relationship between treatment response, genotype, and glycemic status was analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with G-allele of rs3806808 polymorphism showed a worse response to the treatment compared to TT-homozygote patients. Nondiabetic G-allele carriers showed a worse treatment response than TT-homozygotes patients. These differences were not seen in diabetic patients. There were no significant differences in treatment response according to the rs12646525 polymorphism in total population or according to the glycemic status. Logistic regression analysis showed that nondiabetic carriers of the major allele of both the rs12646525 and rs3806808 polymorphism had a significantly higher likelihood to respond to the treatment than diabetic patients carriers of the minor allele (P &amp;lt; .05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The response to sildenafil treatment depends on polymorphisms in the PDE5A gene and the glycemic status of the patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.jsxm.2016.04.075","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T05:11:11Z","timestamp":1464153071000},"page":"1104-1110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["PDE5A Polymorphisms Influence on Sildenafil Treatment Success"],"prefix":"10.1093","volume":"13","author":[{"given":"Cristobal","family":"Marchal-Escalona","sequence":"first","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Malaga, , Spain"},{"name":"University Hospital Virgen de la Victoria \u00a0 \u00a0 , Malaga, , Spain"},{"name":"Campus Universitario de Teatinos s\/n \u00a0 \u00a0 , Malaga, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Herrera-Imbroda","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Malaga, , Spain"},{"name":"University Hospital Virgen de la Victoria \u00a0 \u00a0 , Malaga, , Spain"},{"name":"Campus Universitario de Teatinos s\/n \u00a0 \u00a0 , Malaga, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Clemente-Postigo","sequence":"additional","affiliation":[{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n. CB06\/03 \u00a0 , Madrid, , Spain"},{"name":"Instituto de Salud Carlos III \u00a0 , Madrid, , Spain"},{"name":"Unidad Gesti\u00f3n Cl\u00ednica Endocrinolog\u00eda y Nutrici\u00f3n \u00a0 \u00a0 , , , Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA) \u00a0 \u00a0 , , , Spain"},{"name":"Complejo Hospitalario de M\u00e1laga (Virgen de la Victoria)\/Universidad de M\u00e1laga \u00a0 \u00a0 , , , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Alcaide-Torres","sequence":"additional","affiliation":[{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n. CB06\/03 \u00a0 , Madrid, , Spain"},{"name":"Instituto de Salud Carlos III \u00a0 , Madrid, , Spain"},{"name":"Unidad Gesti\u00f3n Cl\u00ednica Endocrinolog\u00eda y Nutrici\u00f3n \u00a0 \u00a0 , , , Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA) \u00a0 \u00a0 , , , Spain"},{"name":"Complejo Hospitalario de M\u00e1laga (Virgen de la Victoria)\/Universidad de M\u00e1laga \u00a0 \u00a0 , , , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Qui\u00f1onero","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Malaga, , Spain"},{"name":"University Hospital Virgen de la Victoria \u00a0 \u00a0 , Malaga, , Spain"},{"name":"Campus Universitario de Teatinos s\/n \u00a0 \u00a0 , Malaga, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marchal","sequence":"additional","affiliation":[{"name":"Nursing Department \u00a0 , Malaga, , Spain"},{"name":"Hospital Parque S. Antonio \u00a0 , Malaga, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Queipo-Ortu\u00f1o","sequence":"additional","affiliation":[{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n. CB06\/03 \u00a0 , Madrid, , Spain"},{"name":"Instituto de Salud Carlos III \u00a0 , Madrid, , Spain"},{"name":"Unidad Gesti\u00f3n Cl\u00ednica Endocrinolog\u00eda y Nutrici\u00f3n \u00a0 \u00a0 , , , Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA) \u00a0 \u00a0 , , , Spain"},{"name":"Complejo Hospitalario de M\u00e1laga (Virgen de la Victoria)\/Universidad de M\u00e1laga \u00a0 \u00a0 , , , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Mar\u00eda","family":"Arag\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Malaga, , Spain"},{"name":"University Hospital Virgen de la Victoria \u00a0 \u00a0 , Malaga, , Spain"},{"name":"Campus Universitario de Teatinos s\/n \u00a0 \u00a0 , Malaga, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mart\u00edn-Morales","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , M\u00e1laga, , Spain"},{"name":"Hospital Regional de M\u00e1laga \u00a0 , M\u00e1laga, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Fernanda","family":"Lara","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 \u00a0 , Malaga, , Spain"},{"name":"University Hospital Virgen de la Victoria \u00a0 \u00a0 , Malaga, , Spain"},{"name":"Campus Universitario de Teatinos s\/n \u00a0 \u00a0 , Malaga, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cardona","sequence":"additional","affiliation":[{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n. CB06\/03 \u00a0 , Madrid, , Spain"},{"name":"Instituto de Salud Carlos III \u00a0 , Madrid, , Spain"},{"name":"Unidad Gesti\u00f3n Cl\u00ednica Endocrinolog\u00eda y Nutrici\u00f3n \u00a0 \u00a0 , , , Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA) \u00a0 \u00a0 , , , Spain"},{"name":"Complejo Hospitalario de M\u00e1laga (Virgen de la Victoria)\/Universidad de M\u00e1laga \u00a0 \u00a0 , , , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"2024032602342478200_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","article-title":"Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study","volume":"26","author":"Goldstein","year":"2003","journal-title":"Diabetes Care"},{"key":"2024032602342478200_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2024032602342478200_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"2024032602342478200_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2605.2008.00879.x","article-title":"The European Male Ageing Study (EMAS): Design, methods and recruitment","volume":"32","author":"Lee","year":"2009","journal-title":"Int J Androl"},{"key":"2024032602342478200_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0008-6363(99)00135-2","article-title":"Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease?","volume":"43","author":"Sullivan","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2024032602342478200_bib6","first-page":"21295","article-title":"The relation between erectile dysfunction and extent of coronary artery disease in the patients with stable coronary artery disease","volume":"8","author":"Hamur","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2024032602342478200_bib7","article-title":"The association of erectile dysfunction and cardiovascular disease: A systematic critical review","volume-title":"Am J Mens Health","author":"Raheem","year":"2016"},{"key":"2024032602342478200_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ijir.2015.26","article-title":"Modifiable risk factors for erectile dysfunction: An assessment of the awareness of such factors in patients suffering from ischaemic heart disease","volume":"28","author":"Kalka","year":"2016","journal-title":"Int J Impot Res"},{"key":"2024032602342478200_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imj.12937","article-title":"Erectile dysfunction and cardiovascular risk factors in a Mediterranean diet cohort","volume":"46","author":"Ramirez","year":"2016","journal-title":"Intern Med J"},{"key":"2024032602342478200_bib10","first-page":"917","article-title":"Disfunci\u00f3n er\u00e9ctil en pacientes incluidos en un programa de rehabilitaci\u00f3n cardiaca. Rev Esp","volume":"61","author":"Maroto-Montero","year":"2008","journal-title":"Card"},{"key":"2024032602342478200_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-5347(05)65986-1","article-title":"Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la Disfuncion Erectil Masculina Study","volume":"166","author":"Martin-Morales","year":"2001","journal-title":"J Urol"},{"key":"2024032602342478200_bib12","first-page":"589","article-title":"Tratamientos orales de la disfunci\u00f3n er\u00e9ctil","volume-title":"Tratado de androlog\u00eda y medicina sexual","author":"Fiter Gomez"},{"key":"2024032602342478200_bib13","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.2174\/138161206778343064","article-title":"Expression, distribution and regulation of phosphodiesterase 5","volume":"12","author":"Lin","year":"2006","journal-title":"Curr Pharm Des"},{"key":"2024032602342478200_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.2047-2927.2012.00029.x","article-title":"The insertion\/deletion (I\/D) polymorphism in the angiotensin-converting enzyme gene and erectile dysfunction risk: A meta-analysis","volume":"1","author":"Zhang","year":"2013","journal-title":"Andrology"},{"key":"2024032602342478200_bib15","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0022-5347(01)64901-2","article-title":"Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum","volume":"157","author":"Kifor","year":"1997","journal-title":"J Urol"},{"key":"2024032602342478200_bib16","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1111\/j.1743-6109.2010.01968.x","article-title":"Endothelial nitric oxide synthase polymorphisms and erectile dysfunction: A meta-analysis","volume":"7","author":"Wang","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602342478200_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1006\/bbrc.2000.4220","article-title":"Identification and regulation of human PDE5A gene promoter","volume":"280","author":"Lin","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2024032602342478200_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1432-1327.1998.2550391.x","article-title":"Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene","volume":"255","author":"Yanaka","year":"1998","journal-title":"Eur J Biochem"},{"key":"2024032602342478200_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.ijir.3901246","article-title":"Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5)","volume":"16","author":"Salvi","year":"2004","journal-title":"Int J Impot Res"},{"key":"2024032602342478200_bib20","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.ijrobp.2010.07.036","article-title":"Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer","volume":"78","author":"Kerns","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024032602342478200_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.ijir.3900859","article-title":"The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction","volume":"14","author":"Rhoden","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032602342478200_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2165\/00003495-199957060-00015","article-title":"Sildenafil: A review of its use in erectile dysfunction","volume":"57","author":"Langtry","year":"1999","journal-title":"Drugs"},{"key":"2024032602342478200_bib23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","article-title":"Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale","volume":"60","author":"Rosen","year":"2011","journal-title":"Eur Urol"},{"key":"2024032602342478200_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2024032602342478200_bib25","first-page":"131","article-title":"[Sexuality in the elderly]","volume":"38","author":"Wilk","year":"2015","journal-title":"Pol Merkur Lekarski"},{"key":"2024032602342478200_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ijir.2010.1","article-title":"Determinants of erectile dysfunction in type 2 diabetes","volume":"22","author":"Giugliano","year":"2010","journal-title":"Int J Impot Res"},{"key":"2024032602342478200_bib27","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1743-6109.2010.01778.x","article-title":"Definitions\/epidemiology\/risk factors for sexual dysfunction","volume":"7","author":"Lewis","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602342478200_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1051\/jbio\/2004198030237","article-title":"[Cardiovascular risk factors, erection disorders and endothelium dysfunction]","volume":"198","author":"Behr-Roussel","year":"2004","journal-title":"J Soc Biol"},{"key":"2024032602342478200_bib29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/jsm.12497","article-title":"The effect of statins on erectile dysfunction: A systematic review and meta-analysis","volume":"11","author":"Cui","year":"2014","journal-title":"J Sex Med"},{"key":"2024032602342478200_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1464-410X.2005.05614.x","article-title":"Phosphodiesterase type 5 inhibitors for erectile dysfunction","volume":"96","author":"Carson","year":"2005","journal-title":"BJU Int"},{"key":"2024032602342478200_bib31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"2024032602342478200_bib32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/jsm.12828","article-title":"A comprehensive review of metabolic syndrome affecting erectile dysfunction","volume":"12","author":"Kaya","year":"2015","journal-title":"J Sex Med"},{"key":"2024032602342478200_bib33","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1097\/01.ju.0000125198.32936.38","article-title":"The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction","volume":"171","author":"Seftel","year":"2004","journal-title":"J Urol"},{"key":"2024032602342478200_bib34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1743-6109.2012.02649.x","article-title":"Cardiometabolic risk and female sexual health: The Princeton III summary","volume":"9","author":"Miner","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602342478200_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jdiacomp.2010.03.003","article-title":"Diabetes-induced erectile dysfunction: Epidemiology, pathophysiology and management","volume":"25","author":"Thorve","year":"2011","journal-title":"J Diabetes Complications"},{"key":"2024032602342478200_bib36","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.291.24.2978","article-title":"Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial","volume":"291","author":"Esposito","year":"2004","journal-title":"J Am Med Assoc"},{"key":"2024032602342478200_bib37","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.juro.2012.04.001","article-title":"Pilot genome-wide association search identifies potential loci for risk of erectile dysfunction in type 1 diabetes using the DCCT\/EDIC study cohort","volume":"188","author":"Hotaling","year":"2012","journal-title":"J Urol"},{"key":"2024032602342478200_bib38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/01.ju.0000058369.72348.ba","article-title":"Sildenafil response is influenced by the G protein beta 3 subunit GNB3 C825T polymorphism: A pilot study","volume":"169","author":"Sperling","year":"2003","journal-title":"J Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609516301771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609516301771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/13\/7\/1104\/48193298\/jsm_13_7_1104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/13\/7\/1104\/48193298\/jsm_13_7_1104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:43:36Z","timestamp":1711406616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/13\/7\/1104\/6940255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,1]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2016.04.075","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,7]]},"published":{"date-parts":[[2016,7,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDE5A Polymorphisms Influence on Sildenafil Treatment Success","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2016.04.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}